Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 7-13 , January 2007

Carvedilol improved diabetic rat cardiac function depending on antioxidant ability

  • He Huang

      Affiliations

    • Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310016, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 571 88305110; fax: +86 571 86006242.
    • ,
  • Jiang Shan

      Affiliations

    • Department of Cardiology, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
    • ,
  • Xiao-Hong Pan

      Affiliations

    • Department of Cardiology, The 2nd Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
    • ,
  • Hui-Ping Wang

      Affiliations

    • Department of Cardiovascular Physiology, Zhejiang University School of Medicine, Hangzhou, China
    • ,
  • Ling-Bo Qian

      Affiliations

    • Department of Cardiovascular Physiology, Zhejiang University School of Medicine, Hangzhou, China
    • ,
  • Qiang Xia

      Affiliations

    • Department of Cardiovascular Physiology, Zhejiang University School of Medicine, Hangzhou, China

Received 9 November 2005 ,Accepted 26 April 2006.

References 

  1. Beller GA. Coronary heart disease in the first 30 years of the 21st century: challenges and opportunities. The 33rd Annual James B. Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2001;103:2428–2435
  2. Cai L, Kang YJ. Cell death and diabetic cardiomyopathy. Cardiovasc. Toxicol. 2003;3:219–228
  3. Jang JH, Surh YJ. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem. Pharmacol. 2003;66:1371–1379
  4. Refsgaard J, Thomsen C, Andreasen F, Gotzsche O. Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure. Eur. J. Heart Fail. 2002;4:445–453
  5. Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann. Intern. Med. 1997;126:955–959
  6. Noguchi N, Nishino K, Niki E. Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. Biochem. Pharmacol. 2000;59:1069–1076
  7. Rosen P, Rosen R, Hohl C, Reinauer H, Klaus W. Reduced transcoronary exchange and prostaglandin synthesis in diabetes rat heart. Am. J. Physiol. 1984;247:H563–H569
  8. Tao ZW, Huang YW, Xia Q, Xu QW. Early association of electrocardiogram alteration with infarct size and cardiac function after myocardial infarction. J. Zhejiang Univ. Sci. 2004;5:494–498
  9. Li B, Liao YH, Cheng X, Ge H, Guo H, Wang M, et al. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int. J. Cardiol. 2005;22:[Epub ahead of print]
  10. Yang YJ, Gao RL, Tang YD, Zhang P, Ruan YM, Ling YL, et al. Comparative effects of carvedilol, losartan and cilazapril on preventing left ventricular remodeling after acute myocardial infarction in rats. Chinese J. Cardiol. 2001;29:687–690
  11. Huang H, Shang J, Pan XH, Bao XF, Qian LB, Xia Q. Carvedilol protects early diabetic rat hearts through reducing oxidative stress. In: Proceedings of the 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference. Shanghai, China, September 1–4. 2005;
  12. Dandona P, Karne R, Ghanim H, Hamouda W, Aljada A, Magsino CH. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. Circulation. 2000;101:122–124
  13. Jang JH, Surh YJ. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem. Pharmacol. 2003;66:1371–1379
  14. Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF, Buhimschi IA, et al. BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production. Redox Rep. 2001;6:351–362
  15. Zeng H, Liu X, Zhao H. Effects of carvedilol on cardiomyocyte apoptosis and gene expression in vivo after ischemia-reperfusion in rats. J. Huazhong Univ. Sci. Technol. Med. Sci. 2003;23:127–130
  16. Spallarossa P, Garibaldi S, Altieri P, Fabbi P, Manca V, Nasti S, et al. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J. Mol. Cell Cardiol. 2004;37:837–846
  17. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N. Y. Acad. Sci. 2002;4:368–383
  18. Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM. Peroxidative stress in diabetic blood vessels. Reversal by pancreatic islet transplantation. Diabetes. 1985;269:H845–H850
  19. Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. Circ. Res. 1997;1:76–81
  20. Xie YW, Kaminski PM, Wolin MS. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ. Res. 1998;8:891–897
  21. Qin F, Shite J, Mao W, Liang CS. Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function. Eur. J. Pharmacol. 2003;461:149–158
  22. Dalla Libera L, Ravara B, Gobbo V, Danieli Betto D, Germinario E, Angelini A, et al. Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J. Mol. Cell Cardiol. 2005;38:803–807
  23. Oliveira PJ, Esteves T, Rolo AP, Monteiro P, Goncalves L, Palmeira CM, et al. Carvedilol: relation between antioxidant activity and inhibition of the mitochondrial permeability transition. Rev. Port. Cardiol. 2003;1:55–62
  24. Carreira R, Duarte A, Monteiro P, Santos MS, Rego AC, Oliveira CR, et al. Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress. Rev. Port. Cardiol. 2004;23:1447–1455
  25. Schwarz ER, Kersting PH, Reffelmann T, Meven DA, Al-Dashti R, Skobel EC, et al. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart. J. Cardiovasc. Pharmacol. Ther. 2003;8:207–215

PII: S0168-8227(06)00171-9

doi: 10.1016/j.diabres.2006.04.016

Diabetes Research and Clinical Practice
Volume 75, Issue 1 , Pages 7-13 , January 2007

Article Tools

* Image Usage & Resolution